The Joint Corp.

JYNT Healthcare Medical Care Facilities

The Joint Corp.’s revenue for fiscal 2025 (year ended December 2025) was $54.9 million, up 5.24% from fiscal 2024.

Revenue
+14.4%
EPS
+400.0%
Free cash flow
+432.3%

Quarter to June 2026, against a year earlier

6.89 0.48 −6.51%
Market cap
$104.2M
P/E
25.5×
Fwd P/E
20.1×
Dividend yield
—
F-score
7/9
Altman Z
2.39
Beneish M
−2.27
Dividend safety
n/a

The Joint Corp. (JYNT) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, The Joint Corp. (JYNT) trades at a P/E ratio of 25.5×. Over the past ten years it has ranged from 0.0× (September 2025) to 1,458× (March 2019); the current reading is higher than 48% of that period. That is above the Medical Care Facilities industry median of 18.7× and in line with the Healthcare sector median of 24.5×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 45.9× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 451× 259.17%
FY2021 126× 345.16%
FY2020 28.2× (59.76%)
FY2019 70.2× (90.89%)
FY2018 770× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 32.5× (15.49%)
Mar 2026 38.5× (16.16%)
Dec 2025 45.9× (42.27%)
Sep 2025 79.5× —
42 more quarters

Against its own ten years

Low 0.0× High 1,458×
Ten-year median 30.7×
Current reading's percentile 0

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on JYNT